In vivo degradation of three-dimensional silk fibroin scaffolds

Abstract

Three-dimensional porous scaffolds prepared from regenerated silk fibroin using either an all aqueous process or a process involving an organic solvent, hexafluoroisopropanol (HFIP) have shown promise in cell culture and tissue engineering applications. However, their biocompatibility and in vivo degradation has not been fully established. The present study was conducted to systematically investigate how processing method (aqueous vs. organic solvent) and processing variables (silk fibroin concentration and pore size) affect the short-term (up to 2 months) and longterm (up to 1 year) in vivo behavior of the protein scaffolds in both nude and Lewis rats. The samples were analyzed by histology for scaffold morphological changes and tissue ingrowth, and by real-time RT-PCR and immunohistochemistry for immune responses. Throughout the period of implantation, all scaffolds were well-tolerated by the host animals and immune responses to the implants were mild. Most scaffolds prepared from the all aqueous process degraded to completion between two and six months, while those prepared from organic solvent (hexafluoroisopropanol (HFIP)) process persisted beyond one year. Due to widespread cellular invasion throughout the scaffold, the degradation of aqueous-derived scaffolds appears to be more homogeneous than that of HFIP-derived scaffolds. In general and especially for the HFIP-derived scaffolds, a higher original silk fibroin concentration (e.g. 17%) and smaller pore size (e.g. 100-200 µm) resulted in lower levels of tissue ingrowth and slower degradation. These results demonstrate that the in vivo behavior of the three-dimensional silk fibroin scaffolds is related to the morphological and structural features that resulted from different scaffold preparation processes. The insights gained in this study can serve as a guide for processing scenarios to match desired morphological and structural features and degradation time with tissue-specific applications.

Adipose-derived stem cells-seeded bladder acellular matrix graft-silk fibroin enhances bladder reconstruction in a rat model

“…This process is in part caused by extracellular matrix product accumulation in and around regenerating tissue creating an inhospitable growth environment. The host immune system has a significant impact on the degradation of 3D SF porous scaffolds, and the degradation of silk sponges has been shown to be mediated by macrophages [24]. Similarly, it was observed in this study that macrophages clustered around SF fragments and had intracellular SF debris at 4 weeks, suggesting that silk is not only biodegradable but also bioresorbable.…”

Biocompatible silk step-index optical waveguides

“…Nearly all silk processing is done in water without any harsh chemicals making it possible to dope silk devices with cells [14], growth factors [15], and laser dyes [16]. By using a material able to degrade within the body after a period of time, as is possible with silk [17], the need for a second surgery to retrieve the implanted waveguide is eliminated.…”

Implantable, multifunctional, bioresorbable optics

“…Silk proves to be a particularly favorable material for these needs because it provides a convenient connection of material form and biological function. The ability to control the material degradation properties (32) and reform silk biopolymers into technological formats adds opportunity for devices that can seamlessly operate at the nexus of enhanced imaging (through optical transduction), therapy (through drug stabilization and delivery), and quantitative feedback of therapy (through drug-delivery imaging within the same device). The results bear particular promise given the implications of individualized monitoring of drug delivery in vivo and the concepts for multifunctional devices, where a single device can administer a cure while providing information of disease progression.…”